Zydus Lifesciences Q3 Results: Net profit jumps 30% to Rs 1023 croreZydus Lifesciences Q3 Earnings: Zydus Lifesciences reported a 30% YoY rise in Q3FY25 net profit to ₹1,023.5 crore, driven by strong US grow...
Zydus Lifesciences joins hands with CVS Caremark for diabetes drugs template formularyZydus Lifesciences Ltd enters an agreement with CVS Caremark to add Zituvio, Zituvimet, and Zituvimet XR tablets for diabetes treatment to ...
Zydus Lifesciences Q1 results: Net profit jumps 31% to Rs 1420 croreThe earnings before interest, tax, depreciation and ammortisation (EBITDA) increased 38.4% YoY to Rs 2084 crore. On QoQ, EBITDA increased 2...